A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes von Forget, Marie-Andrée, Tavera, René J, Haymaker, Cara, Ramachandran, Renjith, Malu, Shuti, Zhang, Minying, Wardell, Seth, Fulbright, Orenthial J, Toth, Chistopher Leroy, Gonzalez, Audrey M, Thorsen, Shawne T, Flores, Esteban, Wahl, Arely, Peng, Weiyi, Amaria, Rodabe N, Hwu, Patrick, Bernatchez, Chantale

Volltext

Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study von Qin, Yong, Petaccia de Macedo, Mariana, Reuben, Alexandre, Forget, Marie-Andrée, Haymaker, Cara, Bernatchez, Chantale, Spencer, Christine N., Gopalakrishnan, Vancheswaran, Reddy, Sujan, Cooper, Zachary A., Fulbright, Orenthial J., Ramachandran, Renjith, Wahl, Arely, Flores, Esteban, Thorsen, Shawne T., Tavera, Rene J., Conrad, Claudius, Williams, Michelle D., Tetzlaff, Michael T., Wang, Wei-Lien, Gombos, Dan S., Esmaeli, Bita, Amaria, Rodabe N., Hwu, Patrick, Wargo, Jennifer A., Lazar, Alexander J., Patel, Sapna P.

Volltext

Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome von Forget, Marie-Andrée, Haymaker, Cara, Hess, Kenneth R, Meng, Yuzhong Jeff, Creasy, Caitlin, Karpinets, Tatiana, Fulbright, Orenthial J, Roszik, Jason, Woodman, Scott E, Kim, Young Uk, Sakellariou-Thompson, Donastas, Bhatta, Ankit, Wahl, Arely, Flores, Esteban, Thorsen, Shawne T, Tavera, René J, Ramachandran, Renjith, Gonzalez, Audrey M, Toth, Christopher L, Wardell, Seth, Mansaray, Rahmatu, Patel, Vruti, Carpio, Destiny Joy, Vaughn, Carol, Farinas, Chantell M, Velasquez, Portia G, Hwu, Wen-Jen, Patel, Sapna P, Davies, Michael A, Diab, Adi, Glitza, Isabella C, Tawbi, Hussein, Wong, Michael K, Cain, Suzanne, Ross, Merrick I, Lee, Jeffrey E, Gershenwald, Jeffrey E, Lucci, Anthony, Royal, Richard, Cormier, Janice N, Wargo, Jennifer A, Radvanyi, Laszlo G, Torres-Cabala, Carlos A, Beroukhim, Rameen, Hwu, Patrick, Amaria, Rodabe N, Bernatchez, Chantale

Volltext

Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma von Tavera, René J, Forget, Marie-Andrée, Kim, Young Uk, Sakellariou-Thompson, Donastas, Creasy, Caitlin A, Bhatta, Ankit, Fulbright, Orenthial J, Ramachandran, Renjith, Thorsen, Shawne T, Flores, Esteban, Wahl, Arely, Gonzalez, Audrey M, Toth, Christopher, Wardell, Seth, Mansaray, Rahmatu, Radvanyi, Laszlo G, Gombos, Dan S, Patel, Sapna P, Hwu, Patrick, Amaria, Rodabe N, Bernatchez, Chantale, Haymaker, Cara

Volltext

The impact of checkpoint blockade prior to adoptive cell therapy using tumor-infiltrating lymphocytes for metastatic melanoma: An update from MD Anderson Cancer Center von Forget, Marie-Andree, Haymaker, Cara L., Hess, Kenneth R., Roszik, Jason, Woodman, Scott Eric, Fulbright, Orenthial J., Wahl, Arely, Flores, Esteban, Thorsen, Shawne T., Tavera, Rene J., Ramachandran, Renjith, Amaria, Rodabe Navroze, Hwu, Patrick, Bernatchez, Chantale

Volltext